$NMTR I know that some of you like to look at candles. I have talked a lot about the biotech sector (XBI) and that NMTR is simply following it during a period with no company-specific catalysts. Longer-term charts often give strong signals and this week the XBI put in a Dragonfly Doji candle on the weekly charts at support near the 2019 and 2020 lows. Often when a candle like this is seen in combination with support and other technical indicators (i.e., bullish divergence), it can be a sign of an impending reversal. Follow-through is needed in the next week or two to confirm. While the charts are still dogshit and there are many headwinds in the months to come, a bounce into the 85 to 95 range is not out of the question. This is a prior area of consolidation earlier this year and the highs in 2019. That is a 25% to 40% recovery from the current level and may line up really well with positive NMTR data.